econazole has been researched along with bay h 4502 in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (31.58) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 6 (31.58) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodie, AM; Clement, OO; Freeman, CM; Handratta, VD; Hartmann, RW; Njar, VC; Vasaitis, TS | 1 |
| Ekins, S; Harwood, HJ; Hoover, DJ; Lawton, MP; Mankowski, DC; Treadway, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A | 1 |
| Bron, S; Chambon, M; Colau, D; Majjigapu, SR; Michielin, O; Pilotte, L; Röhrig, UF; Turcatti, G; Van den Eynde, BJ; Vogel, P; Zoete, V | 1 |
| Balogh, I; Kim, HY; Koczok, K; Korade, Z; Liu, W; Mirnics, K; Porter, NA; Tallman, KA; Xu, L | 1 |
| Emami, S; Keighobadi, M; Tavangar, P | 1 |
| Bellotti, MG; Dubini, F; Pestellini, V; Riviera, L | 1 |
| Frosch, PJ; Raulin, C | 1 |
| Barba, A; Luciani, P | 1 |
| Bellotti, MG; Fantò, N; Giannotti, D; Giolitti, A; Pestellini, V; Riviera, L | 1 |
| Abbott, AB; Odds, FC; Webster, CE | 1 |
| Döring, HF; Ilgner, M | 1 |
| Qadripur, SA | 1 |
| Hegemann, L; Lahijani, KI; Toso, SM; Uitto, J; Webster, GF | 1 |
| Carrillo-Muñoz, AJ; Torres-Rodriguez, JM | 1 |
| Fauler, G; Köfeler, HC; Leis, HJ; Windischhofer, W | 1 |
| Crawford, F | 1 |
| Borborema, SE; da Costa-Silva, TA; Mesquita, JT; Tempone, AG | 1 |
2 review(s) available for econazole and bay h 4502
| Article | Year |
|---|---|
An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapy.
Topics: 14-alpha Demethylase Inhibitors; Antiprotozoal Agents; Azoles; Humans; Leishmania; Molecular Structure; Sterol 14-Demethylase | 2017 |
Athlete's foot.
Topics: Allylamine; Antifungal Agents; Clotrimazole; Econazole; Humans; Imidazoles; Miconazole; Naphthalenes; Terbinafine; Tinea Pedis | 2005 |
1 trial(s) available for econazole and bay h 4502
| Article | Year |
|---|---|
[Double blind comparative study of 1% econazole cream and 1% bifonazole cream in the treatment of dermatomycoses].
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifungal Agents; Child; Double-Blind Method; Drug Evaluation; Econazole; Female; Humans; Imidazoles; Male; Middle Aged; Ointments; Random Allocation; Tinea | 1988 |
16 other study(ies) available for econazole and bay h 4502
| Article | Year |
|---|---|
Three dimensional pharmacophore modeling of human CYP17 inhibitors. Potential agents for prostate cancer therapy.
Topics: Algorithms; Antineoplastic Agents; Azoles; Binding Sites; Enzyme Inhibitors; Humans; Hydrogen Bonding; Male; Models, Molecular; Prostatic Neoplasms; Protein Binding; Quantitative Structure-Activity Relationship; Steroid 17-alpha-Hydroxylase; Steroids | 2003 |
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors.
Topics: Amides; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Humans; Indoles; Models, Molecular; Oxidoreductases; Quantitative Structure-Activity Relationship; Sterol 14-Demethylase | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity | 2012 |
Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
Topics: Animals; Antifungal Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Molecular Dynamics Simulation; Molecular Structure; Structure-Activity Relationship | 2014 |
The Effect of Small Molecules on Sterol Homeostasis: Measuring 7-Dehydrocholesterol in Dhcr7-Deficient Neuro2a Cells and Human Fibroblasts.
Topics: Animals; Cell Line; Dehydrocholesterols; Dose-Response Relationship, Drug; Fibroblasts; Homeostasis; Humans; Mice; Molecular Conformation; Neurons; Oxidoreductases Acting on CH-CH Group Donors; Small Molecule Libraries; Sterols; Structure-Activity Relationship | 2016 |
Antifungal activity of two benzofuran-imidazoles in different experimental conditions.
Topics: Antifungal Agents; Arthrodermataceae; Candida; Candida albicans; Clotrimazole; Culture Media; Drug Resistance, Microbial; Econazole; Hydrogen-Ion Concentration; Imidazoles; Microbial Sensitivity Tests; Microsporum; Trichophyton | 1991 |
Contact allergy to imidazole antimycotics.
Topics: Adult; Aged; Antifungal Agents; Chemical Phenomena; Chemistry; Clotrimazole; Drug Eruptions; Econazole; Female; Humans; Imidazoles; Male; Miconazole; Middle Aged; Prospective Studies | 1988 |
New benzofuran-imidazoles as antimycotic agents. II. In vitro studies.
Topics: Antifungal Agents; Arthrodermataceae; Benzofurans; Clotrimazole; Econazole; Fungi; Griseofulvin; Hydrogen-Ion Concentration; Imidazoles; Microbial Sensitivity Tests; Yeasts | 1987 |
Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
Topics: Antifungal Agents; Aspergillus; Candida; Clotrimazole; Econazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Morpholines; Triazoles | 1984 |
[Local treatment of rosacea with imidazole derivatives].
Topics: Administration, Topical; Adult; Aged; Clotrimazole; Econazole; Female; Humans; Imidazoles; Male; Metronidazole; Miconazole; Middle Aged; Rosacea | 1983 |
[Antimycotic therapy. 2. Antimycotic chemotherapeutic agents: imidazole derivatives, tolciclate, haloprogin, ciclopiroxolamin].
Topics: Antifungal Agents; Chemical Phenomena; Chemistry; Ciclopirox; Clotrimazole; Dermatomycoses; Econazole; Humans; Imidazoles; Ketoconazole; Miconazole; Phenyl Ethers; Piperazines; Pyridones; Thiocarbamates | 1983 |
Direct interaction of antifungal azole-derivatives with calmodulin: a possible mechanism for their therapeutic activity.
Topics: Antifungal Agents; Calmodulin; Clotrimazole; Drug Interactions; Econazole; Imidazoles; Ketoconazole; Kinetics; Miconazole; Phosphodiesterase Inhibitors; Polymyxin B | 1993 |
In-vitro antifungal activity of sertaconazole, econazole, and bifonazole against Candida spp.
Topics: Antifungal Agents; Candida; Econazole; Imidazoles; Microbial Sensitivity Tests; Thiophenes | 1995 |
Effect of cytochrome P-450 inhibitors econazole, bifonazole and clotrimazole on prostanoid formation.
Topics: Animals; Blood Platelets; Cell Line; Clotrimazole; Cyclooxygenase 1; Cytochrome P-450 Enzyme Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Econazole; Enzyme Inhibitors; Humans; Imidazoles; Ionomycin; Isoenzymes; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Thromboxane B2; Tumor Cells, Cultured | 2000 |
Activity of imidazole compounds on Leishmania (L.) infantum chagasi: reactive oxygen species induced by econazole.
Topics: Antiprotozoal Agents; Cell Membrane; Cell Membrane Permeability; Clotrimazole; Econazole; Imidazoles; Leishmania; Leishmania infantum; Leishmaniasis, Visceral; Membrane Potential, Mitochondrial; Reactive Oxygen Species | 2014 |